TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Karo Pharma Sverige AB
Closing information (x1000 NOK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
270,062
|
239,613
|
277,477 |
Financial expenses |
336
|
132
|
145 |
Earnings before taxes |
-15,916
|
-13,035
|
-1,004 |
EBITDA |
-15,306
|
-86,175
|
7,917 |
Total assets |
288,981
|
312,989
|
149,016 |
Current assets |
288,276
|
311,813
|
104,015 |
Current liabilities |
78,804
|
69,734
|
106,723 |
Equity capital |
210,177
|
243,144
|
42,193 |
- share capital |
153
|
164
|
148 |
Employees (average) |
129
|
93
|
40 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
72.7%
|
77.7%
|
28.3% |
Turnover per employee |
2,094
|
2,576
|
6,937 |
Profit as a percentage of turnover |
-5.9%
|
-5.4%
|
-0.4% |
Return on assets (ROA) |
-5.4%
|
-4.1%
|
-0.6% |
Current ratio |
365.8%
|
447.1%
|
97.5% |
Return on equity (ROE) |
-7.6%
|
-5.4%
|
-2.4% |
Change turnover |
47,005
|
-67,899
|
1,018 |
Change turnover % |
21%
|
-22%
|
0% |
Chg. No. of employees |
36
|
53
|
11 |
Chg. No. of employees % |
39%
|
133%
|
38% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.